Crown Forest Investment Limited Evaluates Biotech Sector Surge in 2025

BRIDGEVIEW, Ill. - EntSun -- Crown Forest Investment Limited, a Hong-Kong based investment advisory firm with sector-specific expertise, today released its mid‑year assessment of the biotechnology industry's strong performance in 2025. The report highlights multiple growth drivers—from breakthrough innovations to mega-deals—underscoring biotech's transformation into a growth powerhouse.

Record Market Expansion

According to industry analysts, the global biotech market is projected to reach $546 billion in 2025, up from $483 billion in 2024—a compound annual growth rate of approximately 13%.

Explosive Licensing Momentum

U.S. pharmaceutical firms have entered 14 licensing agreements worth $18.3 billion with Chinese biotech companies in H1 2025, compared to just two such deals during the same period last year.

More on EntSun News

• IPTVGANG Crowned Best IPTV Service Provider of 2025 by Overwhelming User Acclaim
• Anti-war groups protest vs US-NATO actions in Gaza, Iran, the Global South
• Dr. Jacqueline West Honored as Best Dentist in JAX by Folio Weekly
• Buffalo Producer The MarTian SMG Earns 5x Gold Certification for Key Glock's "Dirt"
• Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars

These deals focused on innovative targeted-cancer and first-in-class therapies, marking a pivotal shift in global R&D sourcing.

Strategic M&A Activity

Big Pharma continues to bolster its pipelines through acquisitions: Eli Lilly is nearing a $1.3 billion deal for gene-editing pioneer Verve Therapeutics, while BioNTech recently agreed to acquire CureVac for $1.25 billion—both moves centered on next-gen therapeutic platforms.

Mega‑Rounds Define Financing Landscape

Biotech venture capital has shifted toward large-scale "megarounds." In Q1 2025, 75% of private biotech funding—approximately $4.1 billion—was raised in rounds exceeding $100 million.

This reflects increasing investor preference for later-stage opportunities.

Innovation Trends: AI & Gene Editing

Advancements in AI‑driven drug discovery and gene-editing—particularly CRISPR therapies—are accelerating clinical acceleration and shaping next-gen pipelines.

More on EntSun News

• Nick Menza Documentary "This Was My Life" now on Blu-ray!
• Miboxer Achieved New Goal in GILE 2025
• Ali Siddiq - Comedian / Master Storyteller Adds 34 More Dates To His 2025
• Jeopardy!'s Ken Jennings Headlines National Mensa Event
• Mensa Foundation Prize Awarded to Neuroscientist-Pianist

Crown Forest Investment Limited

Crown Forest Investment Limited has steadily but firmly established itself as a go-to source for investors looking for information before it hits the streets since its founding in 1989. Join us right now and let us show you the route to a brighter future. Please contact our team representative today and learn more about this unique financial building experience. Our aim is to make your wealth building journey, a simple and enjoyable experience. https://crownforestil.com/

Shira Co
Press Release Officer
+85232482266
info@crownforestil.com
15/F Melbourne Plaza No. 33 Queen's Road, Central, Hong Kong